EP3448391
MEÐFERÐARAÐFERÐIR VIÐ SJÚKDÓMUM ÞAR SEM IL-13-VIRKNI ER SKAÐLEG, MEÐ NOTKUN Á MÓTEFNUM GEGN IL-13
:
EP einkaleyfi í gildi á Íslandi:
27.4.2017:
29.5.2024:
17790401.8
:
24.6.2024:
15.7.2024
:
26.4.2037:
26.4.2026:
30.4.2026
:
METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES
27.4.2017
29.5.2024
24.6.2024
15.7.2024
26.4.2026
:
AbbVie Manufacturing Management Unlimited Company:
70 Sir John Rogerson's Quay, Dublin, 2, IE
:
TIMONY, Gregg:
Carlsbad, CA 92009, US
:
GUJRATHI, Sheila:
Rancho Santa Fe, CA 92067, US
:
PEACH, Robert:
San Diego, CA 92103, US
:
OLSON, Allan:
San Diego, CA 92121, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201662328539 P:
27.4.2016:
US
:
US2017029768:
27.4.2017
:
A61K 31/56, A61K 39/395, A61K 45/06, C07K 16/24
: 9
: 18.3.2025
: 26.4.2026
: Árnason Faktor ehf.